U.S. Maintains Leadership In Global Biotech Rankings

Winter, Peter
May 2013
BioWorld Insight;5/13/2013, Vol. 21 Issue 20, p1
The article discusses the Scientific American Worldview Scorecard, an annual ranking of countries based on the basis of their competitiveness in the field of biotechnology. As per the ranking for 2013 the U.S. leads the list for the fifth consecutive year followed by Denmark and Switzerland. It informs that the score card is prepared on the basis of six categories including Intellectual Property (IP), Intensity, and Enterprise Support.


Related Articles

  • Privatising life. Fraser, Hugh // UNESCO Sources;Nov99, Issue 117, p7 

    Focuses on the issue concerning companies' claim to areas of human life through patent grants in the United States. Firms' ownership of patents; Difference between invention and finding; Intellectual property; Government efforts to prevent private companies from owning patents on human genes. ...

  • Practical and legal preparation for young companies seeking technology transfer. Newiss, Hilary; Horton, Audrey // Journal of Commercial Biotechnology;Spring2001, Vol. 7 Issue 4, p335 

    This paper looks at the basic law of intellectual property as it applies to a small biotechnology company or start-up. It focuses on the systems and attention to paperwork required so that the company can maximise its intellectual property protection.

  • Can You Patent Something Growing in a Petri Dish? Payne, Scott // Grand Rapids Business Journal;5/5/2003, Vol. 21 Issue 18, pB6 

    Focuses on the intellectual property law in the biotechnology sector. Details on the Chakrabarty case; Explanation of lawyers Jim Mitchell and Matt Gipson on the case. INSET: Patent Law Takes Science Background.

  • 21 CFR Part 11: (Un)Expected Added Value. Noferi, Joseph F.; Worden, Daniel E.; Dillon, Ralph // BioPharm International;Feb2002, Vol. 15 Issue 2, p44 

    Focuses on the necessity of implementing the Electronic Records, Electronic Signatures Rule (ERES) to strengthen the intellectual property position of biotechnology companies in the United States. Advantages of the paperless technology; Analysis of the challenges of implementing ERES.

  • TERMINATOR REVISITED?  // New Scientist;7/6/2002, Vol. 175 Issue 2350, p35 

    Focuses on the development of Terminator 2 by the government in the U.S. Management of crop biotechnology; End of the intellectual property robbery; Alteration of the crop varieties.

  • Nontraditional publications and their effect on patentable inventions. Garabedian, Todd E. // Nature Biotechnology;Apr2002, Vol. 20 Issue 4, p401 

    Examines the effect of nontraditional forms of printed publication not confined to technical articles published in research journals on intellectual property rights of a biotechnology company. Role of the U.S. patent laws in providing the inventor to patent his or her invention; Consequence of...

  • Editorial. Ardekani, Ali M. // Avicenna Journal of Medical Biotechnology;Jul-Sep2009, Vol. 1 Issue 2, preceding p55 

    An introduction to the journal is presented in which the editor discusses the themes of articles in the issue, one on the Iranian laws of intellectual property (IP) pertaining to biotechnology, and the sixth National Biotechnology Congress on August 13-15, 2009 in Tehran, Iran.

  • Avoiding common pitfalls. Lytton, Michael // Pharmaceutical Executive;Apr98, Vol. 18 Issue 4, p68 

    Discusses issues as part of an intellectual property due diligence exercise before licensing a biotechnology invention from universities. Review of patent filings made by the university; Performance of a validity analysis on the invention; Other forms of intellectual property protection;...

  • Integrating intellectual property within the organizational social structure. Daizadeh, Iraj // Nature Biotechnology;May2003, Vol. 21 Issue 5, p573 

    Focuses on benefits of integrating intellectual property within the organizational social structure of biotechnology companies. Responsibilities of chief executive officer of a biotechnology company; Activities of business development, licensing, marketing and sales in a biotechnology;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics